Related Experiment Video

Updated: Jun 12, 2026

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases
11:08

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Published on: June 22, 2012

Microparticles in cardiovascular diseases

Marja J VanWijk1, E VanBavel, A Sturk

  • 1Department of Obstetrics and Gynaecology, Academic Medical Center, Amsterdam, The Netherlands.

Cardiovascular Research
|August 12, 2003
PubMed

Insights

Microparticles, small cell-derived vesicles, are increasingly linked to cardiovascular disease pathogenesis. Further research into their composition and function is crucial for developing new treatments.

Area of Science:

  • Cell biology
  • Cardiovascular science
  • Biochemistry

Background:

  • Microparticles are membrane vesicles released from activated or apoptotic cells.
  • Their generation is a regulated process involving distinct cellular pathways.
  • Microparticles exhibit pro-inflammatory, pro-coagulant, and vascular effects.

Purpose of the Study:

  • To explore the likely role of microparticles in cardiovascular disease pathogenesis.
  • To highlight the need for further investigation into microparticle composition and mechanisms of action.

Main Methods:

  • Review of existing literature on microparticle formation and function.
  • Analysis of the association between microparticle characteristics and cardiovascular disease.

Main Results:

  • Circulating microparticle levels are altered in cardiovascular diseases.
  • Microparticles possess properties (pro-inflammatory, pro-coagulant) implicated in cardiovascular pathology.
  • Evidence supporting a role in cardiovascular disease is rapidly accumulating.

Conclusions:

  • Microparticles are likely involved in the pathogenesis of cardiovascular diseases.
  • Understanding microparticle composition and mechanisms is key to developing novel therapeutic strategies.

More Related Videos

Generation of Lymphocytic Microparticles and Detection of their Proapoptotic Effect on Airway Epithelial Cells09:26

Generation of Lymphocytic Microparticles and Detection of their Proapoptotic Effect on Airway Epithelial Cells

Published on: February 20, 2015

Microvascular Embolism Mouse Model for In Vivo Two-photon Microscopy Using Fluorescent Polystyrene Microspheres08:29

Microvascular Embolism Mouse Model for In Vivo Two-photon Microscopy Using Fluorescent Polystyrene Microspheres

Published on: November 21, 2025

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...